|
Volumn 57, Issue 12 SUPPL. 5, 2001, Pages
|
The 5-year risk of MS after optic neuritis: Experience of the optic neuritis treatment trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METHYLPREDNISOLONE;
PLACEBO;
PREDNISONE;
ADULT;
ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISABILITY;
DISEASE COURSE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE SCLEROSIS;
NEUROLOGIC DISEASE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPTIC NERVE DISEASE;
PAIN;
PAPILLEDEMA;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
VISUAL ACUITY;
FEMALE;
HISTORY, 20TH CENTURY;
HUMANS;
MALE;
METHYLPREDNISOLONE;
MULTIPLE SCLEROSIS;
OPTIC NEURITIS;
PREDNISONE;
RANDOMIZED CONTROLLED TRIALS;
RISK;
|
EID: 0035956546
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (29)
|